HCM City (VNA) - Nanocovax, a Made-in-Vietnamvaccine against COVID-19, will be used on humans in a clinical trial from December17.
Do Minh Sy, R&D Director of the vaccine producer - Nanogen PharmaceuticalBiotechnology JSC, said on December 9 that the company’s COVID-19 vaccineresearch and production project has been carried out since March and Nanocovaxhas been developed based on recombinant protein technology.
Like any medicine or vaccine, Nanocovax hasundergone development stages and strict tests, he noted, adding that it hasbeen tested on laboratory mice, hamsters, and monkeys, and shown “verypositive” results, so the firm decided to apply for human trials.
With the Ministry of Health’s permission, the first phase of human trials beginningon December 17 will involve 60 people aged between 18 and 50 and in goodhealth.
After about two to four weeks, they will be tested for COVID-19 antibodies andmove to the second phase, which is set to begin in January next year with about400 volunteers aged 18 to 60.
The third stage will cover 3,000 people between12 and 70 years of age and begin in March, Sy said.
If the human trials are successful, the firmwill manufacture some 2 million doses on a trial basis in the form of injections,nasal spray, and eye drops, to meet the needs of different age groups. Itsmaximum production capacity is about 50 million doses a year, according to Sy.
Apart from Nanocovax, Vietnam has several other COVID-19 candidate vaccinesbeing developed, by Vabiotech, Polyvac, and the Institute of Vaccines andMedical Biologicals./.
Prime Minister Nguyen Xuan Phuc has requested strict punishment for violations of COVID-19 prevention rules committed by individuals and organisations, which had resulted in infections in the community recently.
Minister of Health Nguyen Thanh Long and World Health Organisation (WHO) representative in Vietnam Kidong Park on December 3 co-chaired a health partnership meeting in Hanoi titled “Health Partnerships and Cooperation in Response to the COVID-19 Pandemic”.
Vietnam will conduct the first phase of human trials of a locally made COVID-19 vaccine from December 10, Minister of Health Nguyen Thanh Long said at a meeting with Vietnamese vaccine producers on December 5.
Strict prevention and control measures are still needed as Vietnam would only massively provide a COVID-19 vaccine in the second quarter of 2022 at the earliest, Health Minister Nguyen Thanh Long said at a meeting in Hanoi on December 7.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Testing of the vaccine on mice (Photo: VNA) 
